Question:
Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however,
relapsed many times and after her most recent relapse and she would like to discuss other options.
She is concerned that taking buprenorphine would not represent “true recovery,” because “it is just replacing one drug for another.” You counsel
her that for someone with opioid use disorder as she does, taking buprenorphine is a form of
________________, due to the changes in her brain. The buprenorphine would allow her to function normally with reduced cravings for opioids and without
euphoria. This is in contrast to
________________, in which individuals exhibit ongoing use of a substance despite ongoing adverse consequences resulting from that use.
Format:
Radio buttons (single select)
